Team CHM will be participating in the 2023 TCS New York City Marathon to raise funds for the Choroideremia Research Foundation (CRF) on Sunday, November 5, 2023.

Choroideremia (CHM) is a rare inherited retinal disorder that affects 1 in 50,000 individuals and causes progressive vision loss, ultimately leading to complete blindness. There currently are no treatment options or a cure for CHM. Funds raised will support choroideremia research and education.

* Please note that registering to be a fundraiser does not provide entry into the 2023 TCS New York City Marathon. Registration through this page is for fundraising purposes only.  

If you have questions, please contact us at [email protected] for assistance.